- Home
- BMGL vs INCR Comparison
BMGL vs INCR Comparison
Compare BMGL & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMGL
- INCR
- Stock Information
- Founded
- BMGL 2001
- INCR 1994
- Country
- BMGL Singapore
- INCR Israel
- Employees
- BMGL N/A
- INCR N/A
- Industry
- BMGL
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- BMGL
- INCR Health Care
- Exchange
- BMGL NYSE
- INCR Nasdaq
- Market Cap
- BMGL 75.9M
- INCR 76.7M
- IPO Year
- BMGL 2025
- INCR N/A
- Fundamental
- Price
- BMGL $4.45
- INCR $1.38
- Analyst Decision
- BMGL
- INCR
- Analyst Count
- BMGL 0
- INCR 0
- Target Price
- BMGL N/A
- INCR N/A
- AVG Volume (30 Days)
- BMGL 141.3K
- INCR 18.5K
- Earning Date
- BMGL 01-01-0001
- INCR 04-29-2025
- Dividend Yield
- BMGL N/A
- INCR N/A
- EPS Growth
- BMGL 16.23
- INCR N/A
- EPS
- BMGL 0.09
- INCR N/A
- Revenue
- BMGL $7,428,776.00
- INCR $72,420,918.00
- Revenue This Year
- BMGL N/A
- INCR N/A
- Revenue Next Year
- BMGL N/A
- INCR $39.30
- P/E Ratio
- BMGL $47.29
- INCR N/A
- Revenue Growth
- BMGL 3.32
- INCR N/A
- 52 Week Low
- BMGL $3.63
- INCR $1.17
- 52 Week High
- BMGL $5.50
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- BMGL N/A
- INCR 47.53
- Support Level
- BMGL N/A
- INCR $1.27
- Resistance Level
- BMGL N/A
- INCR $1.31
- Average True Range (ATR)
- BMGL 0.00
- INCR 0.06
- MACD
- BMGL 0.00
- INCR 0.01
- Stochastic Oscillator
- BMGL 0.00
- INCR 73.90
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.